Two Sigma Investments’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Two Sigma Investments’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,675	Closed	-$541K	–	3696
2018 Q2	$541K	Buy	4,675 +972	+26%	+$107K	﹤0.01%	2592
2018 Q1	$366K	Sell	3,703 -6,669	-64%	-$676K	﹤0.01%	2670
2017 Q4	$1.09M	Buy	+10,372	New	+$1.14M	﹤0.01%	1912
2015 Q4	–	Sell	-11,700	Closed	-$1.67M	–	3058
2015 Q3	$1.67M	Buy	11,700 +440	+4%	+$61.5K	0.01%	924
2015 Q2	$1.62M	Buy	11,260 +9,158	+436%	+$1.31M	0.01%	1334
2015 Q1	$296K	Sell	2,102 -5,973	-74%	-$919K	﹤0.01%	2282
2014 Q4	$1.2M	Sell	8,075 -13,396	-62%	-$1.97M	0.01%	1289
2014 Q3	$3.3M	Buy	+21,471	New	+$3.23M	0.01%	733
2013 Q3	–	Sell	-10,168	Closed	-$568K	–	2169
2013 Q2	$568K	Buy	+10,168	New	+$601K	﹤0.01%	1349

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Two Sigma Investments's TARO Position: Q3 2018 in Review

Two Sigma Investments sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2018, closing a stake of 4,675 shares — an estimated $541K sold.

Two Sigma Investments first reported a position in TARO in Q2 2013 and held it in 9 quarters. The position peaked at $3.3M in Q3 2014. 114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

Two Sigma Investments reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2018 after selling out during the quarter.
Two Sigma Investments sold 4,675 Taro Pharmaceutical Industries Ltd. shares in Q3 2018, an estimated $541K.
Two Sigma Investments first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 9 quarters.
Two Sigma Investments's Taro Pharmaceutical Industries Ltd. position peaked at $3.3M in Q3 2014.
114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on Two Sigma Investments's 13F filing for Q3 2018, filed 14 Nov 2018.